EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Randomised Prospective Crossover Study on the Effects of Medium Cut-Off Membranes on FGF-23 and Inflammatory Mediators in Patients Receiving Regular Haemodialysis

Dimitrios Poulikakos, Saif Al-Chalabi, Smeeta Sinha, Philip A Kalra, Dawn Evans, Darren Green, Leon Schurgers, Dimitrios Poulikakos

Blood Purification · 21.04.2025 · 54 (11) · 639-651

DOI: 10.1159/000545745 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Blood Purification, online erschienen am 21.04.2025. Verfasst von Dimitrios Poulikakos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Donal O'Donoghue Renal Research Centre, Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, Salford, UK, saif.alchalabi@nca.nhs.u…. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Inflammation Mediators, Membranes, Artificial, Renal Dialysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In contrast to high-flux dialysis (HFD) membranes, medium cut-off membranes (MCO) can potentially remove a wide range of middle molecules. Our study aimed to compare the clearance rate (CR) of fibroblast growth factor 23 (FGF-23) and other selected inflammatory cytokines between medium MCO and HFD membranes and investigate the intrasubject stability of these biomarkers.

Methods

This prospective randomised case-crossover study recruited 20 adult patients who were randomised into two groups: group A: to start with 1 week of thrice-weekly dialysis using HFD membrane followed by a 3-week washout period and then 1 week of dialysis with an MCO membrane. Group B followed the reverse sequence. Blood samples were taken before and after each dialysis session for the analysis of the assessed biomarkers (FGF-23, interleukin-6 [IL-6], interleukin-18 [IL-18], high-sensitivity C-reactive protein [hsCRP], and dephosphorylated uncarboxylated matrix Gla protein [dp-ucMGP]). Wilcoxon signed rank and paired t tests were used for comparison between the membranes. One-way repeated measures ANOVA or Friedman tests were used for the intrasubject stability of the biomarkers.

Results

The use of both MCO and HFD membranes resulted in a significant reduction of FGF-23 levels and other selected inflammatory cytokines. However, there was no significant difference in the CR: FGF-23 (0.31 vs. 0.23], p = 0.242), IL-6 (0.19 vs. 0.12, p = 0.215), IL-18 (−0.05 vs. −0.03, p = 0.704), dp-ucMGP (0.33 vs. 0.33, p = 0.903), and hsCRP (−0.05 vs. −0.08, p = 0.107). There was no significant intrasubject variability for all assessed biomarkers except in pre-dialysis high hsCRP levels when using HFD membrane.

Conclusion

The use of both MCO and HFD membranes resulted in a significant reduction of FGF-23 levels and other selected inflammatory cytokines. However, the MCO membrane did not demonstrate a significant advantage over the HFD in the short term. There was no significant intrasubject variability for all assessed biomarkers apart from hsCRP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23Inflammation MediatorsMembranes, ArtificialRenal DialysisAdultAgedFemaleHumansMaleMiddle AgedBiomarkersCross-Over StudiesProspective Studies

Stichwörter der Autor:innen

Chronic kidney diseaseFibroblast growth factor-23HaemodialysisIntrasubject stabilityMedium cut-off membrane

Substanzen

BiomarkersFGF23 protein, humanFibroblast Growth Factor-23Inflammation MediatorsMembranes, Artificial

Autor:innen und Institutionen

  • Donal O'Donoghue Renal Research Centre, Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, Salford, UK, saif.alchalabi@nca.nhs.uk.
  • Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK, saif.alchalabi@nca.nhs.uk.
  • Donal O'Donoghue Renal Research Centre, Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, Salford, UK.
  • Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, UK.
  • Cardiovascular Research Institute (CRIM), Department of Biochemistry, University Maastricht, Maastricht, The Netherlands.

Zitieren

APA

Poulikakos, D., Al-Chalabi, S., Sinha, S., Kalra, P. A., Evans, D., Green, D., Schurgers, L., & Poulikakos, D. (2025). A Randomised Prospective Crossover Study on the Effects of Medium Cut-Off Membranes on FGF-23 and Inflammatory Mediators in Patients Receiving Regular Haemodialysis. Blood Purification, 54(11), 639-651. https://doi.org/10.1159/000545745

Vancouver

Poulikakos D, Al-Chalabi S, Sinha S, Kalra PA, Evans D, Green D, et al. A Randomised Prospective Crossover Study on the Effects of Medium Cut-Off Membranes on FGF-23 and Inflammatory Mediators in Patients Receiving Regular Haemodialysis. Blood Purification. 2025;54(11):639-651. doi:10.1159/000545745

BibTeX
@article{Poulikakos2025,
  author = {Poulikakos, Dimitrios and Al-Chalabi, Saif and Sinha, Smeeta and Kalra, Philip A and Evans, Dawn and Green, Darren and Schurgers, Leon and Poulikakos, Dimitrios},
  title = {A Randomised Prospective Crossover Study on the Effects of Medium Cut-Off Membranes on FGF-23 and Inflammatory Mediators in Patients Receiving Regular Haemodialysis},
  journal = {Blood Purification},
  year = {2025},
  volume = {54},
  number = {11},
  pages = {639--651},
  doi = {10.1159/000545745}
}
Kostenlos starten →